David Ben-Ami

David Ben-Ami

Private Equity Investor bij NOVOLOG (PHARM-UP 1966) LTD

63 jaar
Health Technology
Finance
Consumer Non-Durables

Profiel

David Ben-Ami founded Joy Ventures in 2017, where he worked as Director from 2017 to 2023.
Mr. Ben-Ami also currently works at ConTIPI Medical Ltd., as Director, Novolog (Pharm UP 1966) Ltd., as Director from 2017, SBI Japan-Israel Innovation Fund, as Executive Investment Director, ImmunoBrain Checkpoint Ltd., as Director from 2017, Orasis Pharmaceuticals Ltd., as Director, Corundum Open Innovation Ltd., as Managing Partner from 2016, and SBI JI Innovation Advisory Ltd., as General Partner from 2017.
Mr. Ben-Ami also formerly worked at NVR Labs, Inc., as Chief Executive Officer from 2005 to 2010, Macrocure Ltd., as Chairman from 2008 to 2015, Boston Scientific Corp., as Director from 2003 to 2005, Wilk Technologies Ltd., as Independent Director, Ovalum Ltd., as Director, Quark Pharmaceuticals, Inc., as Director from 2018 to 2020, Biocell Pty Ltd., as Director from 2008 to 2015, ElectReon Wireless Ltd., as Director, Teva Navot - Distribution Ltd., as Director-Business Development, Teva North America, as Director-Business Development from 1999 to 2003, Meytav Technological Enterprises Innovation Center Ltd., as Director, Degania Silicone Ltd., as Director from 2010 to 2016, Boston Scientific Israel Ltd., as Director, Entera Bio Ltd., as Director from 2014 to 2018, Nanothera Ltd., as Director, Hairstetics Ltd., as Director, Novolog Ltd., as Director, V.V.T.
Med Ltd., as Director from 2008 to 2019, Chemomab Ltd., as Director from 2017 to 2021, VVT Medical Ltd., as Director, and Teva Medical Ltd., as Director-Business Development from 1999 to 2002.
Mr. Ben-Ami received his undergraduate degree in 1986 and Masters Business Admin degree in 1987 from Tel-Aviv University.

Actieve functies van David Ben-Ami

BedrijvenFunctieBegin
NOVOLOG (PHARM-UP 1966) LTD Private Equity Investor 14-05-2017
Chief Investment Officer -
Directeur/Bestuurslid -
Private Equity Investor 01-10-2017
Private Equity Investor 01-01-2017
Directeur/Bestuurslid -
Corundum Open Innovation Ltd. Private Equity Investor 01-05-2016
Alle actieve functies van David Ben-Ami

Eerdere bekende functies van David Ben-Ami

BedrijvenFunctieEinde
Oprichter 01-07-2023
Directeur/Bestuurslid 01-03-2021
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Ervaring van David Ben-Ami in detail bekijken

Opleiding van David Ben-Ami

Tel-Aviv University Masters Business Admin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van David Ben-Ami in detail bekijken

Connecties

97

Eerstegraads connecties

30

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven5
BOSTON SCIENTIFIC CORPORATION

Health Technology

ELECTREON WIRELESS LTD

Producer Manufacturing

WILK TECHNOLOGIES LTD

Commercial Services

ENTERA BIO LTD.

Health Technology

NOVOLOG (PHARM-UP 1966) LTD

Distribution Services

Bedrijven in privébezit24

Health Technology

Corundum Open Innovation Ltd.

Finance

Teva North America

NVR Labs, Inc.

Boston Scientific Israel Ltd.

Consumer Non-Durables

Health Technology

Nanothera Ltd.

Health Technology

Health Technology

Health Technology

Finance

Finance

Health Technology

VVT Medical Ltd.

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Services

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. David Ben-Ami
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU